Abstract:Lytic bacteriophages hold substantial promise in medical and biotechnological applications. Therefore a comprehensive understanding of phage infection mechanisms is crucial. CRISPR-Cas systems offer a way to explore these mechanisms via site-specific phage mutagenesis. However, phages can resist Cas-mediated cleavage through extensive DNA modifications like cytosine glycosylation, hindering mutagenesis efficiency. Our study utilizes the eukaryotic enzyme NgTET to temporarily reduce phage DNA modifications, facilitating Cas nuclease cleavage and enhancing mutagenesis efficiency. This approach enables precise DNA targeting and seamless point mutation integration, exemplified by deactivating specific ADP-ribosyltransferases crucial for phage infection. Furthermore, by temporally removing DNA modifications, we elucidated the effects of these modifications on T4 phage infections without necessitating gene deletions. Our results present a strategy enabling the investigation of phage epigenome functions and streamlining the engineering of phages with cytosine DNA modifications. The described temporal modulation of the phage epigenome is valuable for synthetic biology and fundamental research to comprehend phage infection mechanisms through the generation of mutants. Bacteriophages, viruses that target bacteria, hold substantial promise for applications in biotechnological and medical settings. A comprehensive understanding of their infection mechanisms is essential for harnessing their full potential in these fields. To study the mechanisms underlying efficient phage infection, mutagenesis of the bacteriophage genome is the key. While CRISPR-Cas offers a powerful tool for performing mutagenesis in various organisms in a site-specific manner, its application is limited to bacteriophages due to the extensive modification of bacteriophage DNA, collectively termed the epigenome. For bacteriophages with highly modified genomes, e. g. bacteriophage T4, the DNA modifications impede Cas nuclease targeting–a crucial step in CRISPR-Cas mutagenesis. In our study, we introduce a temporal modulation of the bacteriophage epigenome, allowing us to decrease the abundance of bacteriophage DNA modifications. This approach enables the investigation of the biological role of the bacteriophage epigenome and allows for its efficient targeting by Cas nucleases, permitting successful phage mutagenesis. Our approach to modulating the bacteriophage epigenome not only deepens the understanding of bacteriophage infection mechanisms through mutagenesis but also holds significant potential for synthetic biology. This advancement paves the way for the efficient engineering of phages, enhancing their application in biotechnological and medical fields.

[Editing of Phage Genomes - Recombineering-Assisted SpCas9 Modification of Model Coliphages T7, T5, and T3]

Repurposing an Endogenous CRISPR-Cas System to Generate and Study Subtle Mutations in Bacteriophages

Genetic manipulation of Bacteriophage T4 utilizing the CRISPR-Cas13b system

Strategies for Editing Virulent Staphylococcal Phages Using CRISPR-Cas10

CRISPR Gene Editing of a Virulent Bacteriophage

Use of Cas9 Targeting and Red Recombination for Designer Phage Engineering

Continuous multiplexed phage genome editing using recombitrons

Temporal epigenome modulation enables efficient bacteriophage engineering and functional analysis of phage DNA modifications

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Utilizing Golden Gate Assembly to Streamline CRISPR-Cas/NgTET-Based Phage Mutagenesis

An efficient, scarless, selection-free technology for phage engineering

Fine-Tuning Cas9 Activity with a Cognate Inhibitor AcrIIA4 to Improve Genome Editing in <i>Streptomyces</i>

CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool

Programming CRISPRi-dCas9 to control the lifecycle of bacteriophage T7

Engineering T4 Bacteriophage for In Vivo Display by Type V CRISPR-Cas Genome Editing

Development of the CRISPR-Cas12a system for editing of Pseudomonas aeruginosa phages

Phage-delivered CRISPR-Cas9 for strain-specific depletion and genomic deletions in the gut microbiome

Engineering bacteriophages for enhanced host range and efficacy: insights from bacteriophage-bacteria interactions

Repurposing CRISPR-Cas Systems as Genetic Tools for the Enterobacteriales

A plasmid toolset for CRISPR-mediated genome editing and CRISPRi gene regulation in Escherichia coli